Letters to the Editor

• Clinical management in cardiology. Extended hospitalization

  Alejandro Virgós Lamela, José R. González-Juanatey

  Rev Esp Cardiol. 2022;75:282-4

• How to reduce the risk of residual shunt during percutaneous treatment of ventricular septal defects

  Fanyan Luo, Haisong Bu

  Rev Esp Cardiol. 2022;75:279

• The alcohol-intake paradox: caution in a field of developing evidence

  Martín Negreira-Caamaño, José Abellán-Huerta

  Rev Esp Cardiol. 2022;75:190-1

• The alcohol-intake paradox: caution in a field of developing evidence. Response

  Ramón Estruch, Emilio Sacanella

  Rev Esp Cardiol. 2022;75:191

• “Echocardiographic response” to sacubitril-valsartan: does it decrease defibrillation implantation, as well as the incidence of malignant arrhythmias? Response

  Laia Carla Belarte-Tornero, Diana Mojón, Núria Farré

  Rev Esp Cardiol. 2022;75:108

• Nonpermanent atrial fibrillation in the new European Society of Cardiology guidelines

  Eduardo Vázquez Ruiz de Castroviejo, Antonio Linde Estrella, Francisco Manuel García García, Juan Carlos Fernández Guerrero

  Rev Esp Cardiol. 2022;75:103-4

• Nonpermanent atrial fibrillation in the new European Society of Cardiology guidelines. Response

  David Calvo, Elena Arbelo

  Rev Esp Cardiol. 2022;75:104

• Relevance of myocardial injury biomarkers to the prognosis of COVID-19 patients

  Eric Alcaide, Laia Álvarez Bota, Rosario Salas

  Rev Esp Cardiol. 2022;75:105

• Relevance of myocardial injury biomarkers to the prognosis of COVID-19 patients. Response

  Alicia Calvo-Fernández, Jaume Marrugat, Beatriz Vaquerizo

  Rev Esp Cardiol. 2022;75:106

• “Echocardiographic response” to sacubitril-valsartan: does it decrease defibrillation implantation, as well as the incidence of malignant arrhythmias?

  Beatriz Jáuregui, Juan Acosta, Xavier Bosch, Antonio Berruezo

  Rev Esp Cardiol. 2022;75:107-8

• Ischemic heart disease and acute cardiac care: an indisoluble binomial

  Pablo Jorge, Albert Ariza-Solé, on behalf of the Executive Committee of the Association for Ischemic Heart Disease and Acute Cardiovascular Care of the Spanish Society of Cardiology

  Rev Esp Cardiol. 2021;74:1002

• Percutaneous left atrial appendage closure in the presence of thrombus: the safer, the better

  Francisco Torres-Saura, Ignacio Cruz-González, Ernesto Raúl Centurión-Inda, Eduardo Arroyo-Úcar

  Rev Esp Cardiol. 2021;74:894

• Percutaneous left atrial appendage closure in the presence of thrombus: the safer, the better. Response

  Adolfo Fontenla, Iván Gómez-Blázquez, Cecilia Corros-Vicente, Fernando Arribas-Ynsaurriaga

  Rev Esp Cardiol. 2021;74:895

• The danger of meta-analyses. Response

  Monica Verdoia, Elvin Kedhi, Giuseppe De Luca

  Rev Esp Cardiol. 2021;74:817-8

• Artificial intelligence in echocardiography

  Mónica Regalado Chamorro, Aldo Medina Gamero

  Rev Esp Cardiol. 2021;74:815

• The danger of meta-analyses

  Daniel Hernández-Vaquero, Rocío Díaz, Pablo Avanzas, Alberto Domínguez-Rodríguez

  Rev Esp Cardiol. 2021;74:815-7

• Gender and ST-elevation myocardial infarction

  Antonia Sambola, Luis Rodríguez-Padial, José Luis Bernal, Francisco Javier Elola

  Rev Esp Cardiol. 2021;74:724

• Gender and ST-elevation myocardial infarction. Response

  Helena Tizón-Marcos, Isaac Subirana, Jaume Marrugat

  Rev Esp Cardiol. 2021;74:725

• Relationship between patent foramen ovale and COVID-19 in patients admitted to an intensive care unit

  Saber Eskandari, Pooya Jalali

  Rev Esp Cardiol. 2021;74:725-6

• Medical associations in the 21st century. Reflections in the wake of the agreement between the Spanish Heart Foundation and the Official Physicians Association of Madrid

  Manuel Martínez-Sellés, Francisco Javier Martín-Sánchez

  Rev Esp Cardiol. 2021;74:727-8